T. Rowe Price Investment Management’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.1M | Buy |
10,512,134
+112,893
| +1% | +$280K | 0.02% | 470 |
|
|
2025
Q1 | $16.1M | Sell |
10,399,241
-67,480
| -0.6% | -$105K | 0.01% | 532 |
|
|
2024
Q4 | $22.4M | Sell |
10,466,721
-267,668
| -2% | -$573K | 0.01% | 503 |
|
|
2024
Q3 | $46.7M | Buy |
10,734,389
+74,659
| +0.7% | +$325K | 0.03% | 414 |
|
|
2024
Q2 | $49.7M | Buy |
10,659,730
+3,934,365
| +59% | +$18.3M | 0.03% | 389 |
|
|
2024
Q1 | $34.1M | Buy |
6,725,365
+2,797,486
| +71% | +$14.2M | 0.02% | 450 |
|
|
2023
Q4 | $11M | Buy |
3,927,879
+1,774,291
| +82% | +$4.99M | 0.01% | 509 |
|
|
2023
Q3 | $6.18M | Buy |
+2,153,588
| New | +$6.18M | ﹤0.01% | 537 |
|